TickerFacts.

Cosmos Health Inc. (COSM): Long-Term Debt

Annual figures by period end, from SEC filings.

$3.78M
As of 2025-12-31
$3.19M
As of 2026-06-30
-9.0%
3-year compound annual growth
-18.9%
5-year compound annual growth
$17.91M2018-12-31: $145.5K2019-12-31: $02020-12-31: $10.77M2021-12-31: $17.91M2022-12-31: $5.02M2023-12-31: $4.61M2024-12-31: $4.11M2025-12-31: $3.78M$3.78M
2018-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$3.78M-8.1%2026-04-15, Balance as of period end
2024-12-31$4.11M-10.8%2025-04-15, Balance as of period end
2023-12-31$4.61M-8.2%2024-08-05, Balance as of period end
2022-12-31$5.02M-72.0%2023-04-12, Balance as of period end
2021-12-31$17.91M+66.2%2022-12-16, Balance as of period end
2020-12-31$10.77Mn/a2021-04-15, Balance as of period end
2019-12-31$0-100.0%2021-04-15, Balance as of period end
2018-12-31$145.5Kn/a2020-04-14, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Cosmos Health Inc. (COSM)2025-12-31$3.78M-8.1%
DataMeds AI, Inc. (MEDS)2025-12-31$23.49M+0.4%
Stemtech Corp (STEK)2025-12-31$4.16M+9.1%
Herbalife Ltd. (HLF)2025-12-31$1.99B-11.8%
Cencora, Inc. (COR)2025-09-30$7.66B+74.6%
McKesson Corp (MCK)2026-03-31$6.53B+15.4%

Compare COSM, MEDS, STEK, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗